It has been reported that cyclin A1 and cyclin D1 were transcriptional targets of SIX1 and that SIX1 promoted cell proliferation in breast cancer by increasing cyclin A1 expression [56] and in pancreatic cancer via increasing cyclin D1 expression [57]. Here, CCND1 is linked to breast carcinoma.